These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7624585)

  • 1. [Role of bone marrow plasma cell kinetics in the differential diagnosis of monoclonal gammopathies].
    Pini E; Tassinari D; Gianni L; Fattori P; Sartori S; Pasquini E; Ravaioli A
    Recenti Prog Med; 1995 Jun; 86(6):242. PubMed ID: 7624585
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunophenotypic aberrations, DNA content, and cell cycle analysis of plasma cells in patients with myeloma and monoclonal gammopathies.
    Lima M; Teixeira Mdos A; Fonseca S; Gonçalves C; Guerra M; Queirós ML; Santos AH; Coutinho A; Pinho L; Marques L; Cunha M; Ribeiro P; Xavier L; Vieira H; Pinto P; Justiça B
    Blood Cells Mol Dis; 2000 Dec; 26(6):634-45. PubMed ID: 11358356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of plasma cell acid phosphatase in the differential diagnosis of monoclonal gammopathies].
    Santus G; Pirali F; Inzoli MR
    Minerva Med; 1981 Sep; 72(37):2479-83. PubMed ID: 7279268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multiple myeloma -- diagnostics].
    Schroers R; Zettl F; Jung W
    Dtsch Med Wochenschr; 2005 Feb; 130(6):278-82; quiz 287-90. PubMed ID: 15692902
    [No Abstract]   [Full Text] [Related]  

  • 5. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
    Martín P; Santón A; Bellas C
    Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Importance of selected laboratory indicators in the differential diagnosis and monitoring of multiple myeloma].
    Maisnar V; Tousková M; Malý J; Krejsek J; Kmonícek M; Kopecký O
    Vnitr Lek; 2002 Apr; 48(4):290-7. PubMed ID: 12061177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma cell acid phosphatase in the differential diagnosis of monoclonal gammopathies].
    Milanesi B; Tafuri C; Perini M; Rota G; Peretti P
    Quad Sclavo Diagn; 1984 Jun; 20(2):149-54. PubMed ID: 6528014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discriminating analysis in the differential diagnosis of monoclonal gammopathies.
    Büchi G; Veglio M; Reviglione G; Grosso E; Termine G; Girotto M; Autino R
    Pathologica; 1993; 85(1096):175-81. PubMed ID: 8361780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytological study of acid phosphatase activity of plasma cells in monoclonal gammopathies].
    Ricci C; Coscia GG; Bellone G; Novarini M; Discalzi GL; Cascio G
    Acta Med Austriaca; 1984; 11(2):37-43. PubMed ID: 6741437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells.
    Ng AP; Wei A; Bhurani D; Chapple P; Feleppa F; Juneja S
    Haematologica; 2006 Jul; 91(7):972-5. PubMed ID: 16818287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell proliferation of myeloma plasma cells: comparison of the blood and marrow compartments.
    Kumar S; Rajkumar SV; Greipp PR; Witzig TE
    Am J Hematol; 2004 Sep; 77(1):7-11. PubMed ID: 15307099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Laboratory diagnosis of myeloma disease (review of the literature)].
    Lugovskaia SA
    Vrach Delo; 1982 Jan; (1):57-61. PubMed ID: 7041423
    [No Abstract]   [Full Text] [Related]  

  • 13. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
    Sezer O; Heider U; Zavrski I; Possinger K
    Haematologica; 2001 Aug; 86(8):837-43. PubMed ID: 11522540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the usefulness of bone marrow sections and smears in diagnosis of multiple myeloma.
    Buss DH; Prichard RW; Hartz JW; Cooper MR
    Hematol Pathol; 1987; 1(1):35-43. PubMed ID: 3504429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis versus differential diagnosis of multiple myeloma].
    Bessmel'tsev SS
    Vopr Onkol; 2004; 50(4):406-16. PubMed ID: 15605762
    [No Abstract]   [Full Text] [Related]  

  • 16. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.
    International Myeloma Working Group
    Br J Haematol; 2003 Jun; 121(5):749-57. PubMed ID: 12780789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign and malignant monoclonal gammopathies.
    Carney DN; Bunn PA
    Prim Care; 1980 Sep; 7(3):369-94. PubMed ID: 6777792
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma cell acid phosphatase, a discriminative test for benign and malignant monoclonal gammopathies.
    Cassuto JP; Hammou JC; Pastorelli E; Dujardin P; Masseyeff R
    Biomedicine; 1977 Jul; 27(5):197-9. PubMed ID: 922119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness and reproducibility of cytomorphologic evaluations to differentiate myeloma from monoclonal gammopathies of unknown significance.
    Millá F; Oriol A; Aguilar J; Aventín A; Ayats R; Alonso E; Domingo A; Feliu E; Florensa L; López A; Pérez-Vila E; Rozman M; Sánchez C; Vallespí T; Woessner S
    Am J Clin Pathol; 2001 Jan; 115(1):127-35. PubMed ID: 11190798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow T-cell subsets in patients with monoclonal gammopathies: correlation with clinical stage and disease status.
    Corso A; Castelli G; Pagnucco G; Lazzarino M; Bellio L; Klersy C; Bernasconi C
    Haematologica; 1997; 82(1):43-6. PubMed ID: 9107081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.